[1] |
Li X, Eriksson U. Novel PDGF family members: PDGF-C and PDGF-D[J]. Cytokine Growth Factor Rev, 2003, 14(2): 91-98. DOI: 10.1016/S1359-6101(02)00090-4.
|
[2] |
Li C, Shintani S, Terakado N, et al. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas[J]. Int J Oral Maxillofac Surg, 2005, 34(5): 559-565. DOI: 10.1016/j.ijom.2004.10.016.
|
[3] |
Liu J, Liao S, Huang Y, et al. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer[J]. Clinical Cancer Research, 2011, 17(11): 3638-3648. DOI: 10.1158/1078-0432.CCR-10-2456.
|
[4] |
Lokker NA, Sullivan CM, Hollenbach SJ, et al. Platelet-derived growth factor(PDGF)autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors[J]. Cancer Res, 2002, 62(13): 3729-3735. DOI: 10.1046/j.1523-5394.2002.104006.x.
|
[5] |
Ustach CV, Kim HR. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells[J]. Mol Cell Biol, 2005, 25(14): 6279-6288. DOI: 10.1128/MCB.25.14.6279-6288.2005.
|
[6] |
Li G, Qin Z, Chen Z, et al. Tumor Microenvironment in Treatment of Glioma[J]. Open Med, 2017, 12(1): 247-251. DOI: 10.1515/med-2017-0035.
|
[7] |
Bhardwaj B, Klassen J, Cossette N, et al. Localization of platelet-derived growth factor beta receptor expression in the periepithelial stroma of human breast carcinoma[J]. Clin Cancer Res, 1996, 2(4): 773-782. DOI: 10.1093/carcin/17.4.889.
|
[8] |
Kawai T, Hiroi S, Torikata C. Expression in lung carcinomas of platelet-derived growth factor and its receptors[J]. Lab Invest, 1997, 77(5): 431-436. DOI: 10.1007/s001090050182.
|
[9] |
Devarajan E, Song YH, Krishnappa S, et al. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells[J]. Int J Cancer, 2012, 131(5): 1023-1031. doi: 10.1002/ijc.26493.
|
[10] |
Kong D, Wang Z, Sarkar SH, et al. Platelet-Derived Growth Factor-D Overexpression Contributes to Epithelial-Mesenchymal Transition of PC3 Prostate Cancer Cells[J]. Stem Cells(Dayton, Ohio), 2008, 26(6): 1425-1435. DOI: 10.1634/stemcells.2007-1076.
|
[11] |
Wang Y, Qiu H, Hu W, et al. Over-Expression of Platelet-Derived Growth Factor-D Promotes Tumor Growth and Invasion in Endometrial Cancer[J]. International Journal of Molecular Sciences, 2014, 15(3): 4780-4794. DOI: 10.3390/ijms15034780.
|
[12] |
Kong D, Li Y, Wang Z, et al. miR-200 Regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells[J]. Stem Cells, 2009, 27(8): 1712-1721. DOI: 10.1002/stem.101.
|
[13] |
Zhang J, Zhang H, Chen Y, et al. Platelet derived growth factor D promotes the angiogenic capacity of endothelial progenitor cells[J]. Mol Med Rep, 2019, 19(1): 125-132. DOI: 10.3892/mmr.2018.9692.
|